Published in Law and Health Weekly, October 29th, 2005
"This study was undertaken to compare the MR rates of 2 regimens, CLI and ATT, in the treatment of Stage I-III follicular lymphoma. MR was defined as disappearance of t(14;18) (q32;q21) amplified by polymerase chain reaction (PCR). Sixty-five patients with Stage I to III follicular lymphoma were randomized," scientists in the United States reported.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.